Overview
Tomas Adam practices in Olomouc, Czech Republic. Mr. Adam is rated as a Distinguished expert by MediFind in the treatment of Carnitine Palmitoyltransferase 1 Deficiency. His top areas of expertise are Carnitine Palmitoyltransferase 1 Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, Adenylosuccinate Lyase Deficiency, and Medium-Chain Acyl-CoA Dehydrogenase Deficiency.
His clinical research consists of co-authoring 36 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Carnitine Palmitoyltransferase 1 Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency
- Carnitine Palmitoyltransferase 1 Deficiency
- Advanced
- Adenylosuccinate Lyase Deficiency
- Carnitine-Acylcarnitine Translocase Deficiency
- Medium-Chain Acyl-CoA Dehydrogenase Deficiency
- Experienced
- Chronic Myelogenous Leukemia (CML)Mr. Adam isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Glutaric Acidemia Type 1Mr. Adam isExperienced. Learn about Glutaric Acidemia Type 1.
- Homocystinuria due to MTHFR Deficiency
- Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
- Mitochondrial Trifunctional Protein Deficiency
- Patent Foramen OvaleMr. Adam isExperienced. Learn about Patent Foramen Ovale.